Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 24, 2014, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $820.00 to $144,690,560.42.

Highlighted Stocks Traded by Insiders:

Hawaiian Holdings (HA) - FREE Research Report

Nardello Charles R who is SVP-Operations at Hawaiian Holdings sold 40,000 shares at $14.28 on March 24, 2014. Following this transaction, the SVP-Operations owned 77,823 shares meaning that the stake was reduced by 33.95% with the 40,000-share transaction.

The shares most recently traded at $14.07, down $0.21, or 1.51% since the insider transaction. Historical insider transactions for Hawaiian Holdings go as follows:

  • 4-Week # shares sold: 60,500
  • 12-Week # shares sold: 60,500
  • 24-Week # shares bought: 9,209
  • 24-Week # shares sold: 60,500

The average volume for Hawaiian Holdings has been 1.4 million shares per day over the past 30 days. Hawaiian Holdings has a market cap of $732.4 million and is part of the services sector and transportation industry. Shares are up 42.58% year-to-date as of the close of trading on Monday.

Hawaiian Holdings, Inc., through its subsidiary, Hawaiian Airlines, Inc., is engaged in the scheduled air transportation of passengers and cargo. The company has a P/E ratio of 15.0. Currently there are 3 analysts that rate Hawaiian Holdings a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HA - FREE

TheStreet Quant Ratings

rates Hawaiian Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and attractive valuation levels. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and poor profit margins. Get the full

Hawaiian Holdings Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Endocyte (ECYT) - FREE Research Report

Ritter Allen R who is VP of Manufacturing/CMC at Endocyte sold 8,000 shares at $33.11 on March 24, 2014. Following this transaction, the VP of Manufacturing/CMC owned 12,722 shares meaning that the stake was reduced by 38.61% with the 8,000-share transaction.

The shares most recently traded at $28.64, down $4.47, or 15.61% since the insider transaction. Historical insider transactions for Endocyte go as follows:

  • 4-Week # shares sold: 6,000
  • 12-Week # shares sold: 6,000
  • 24-Week # shares sold: 6,000

The average volume for Endocyte has been 829,300 shares per day over the past 30 days. Endocyte has a market cap of $1.0 billion and is part of the health care sector and drugs industry. Shares are up 154.87% year-to-date as of the close of trading on Monday.

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics. Currently there are 6 analysts that rate Endocyte a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ECYT - FREE

TheStreet Quant Ratings

rates Endocyte as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and disappointing return on equity. Get the full

Endocyte Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

SPX Corporation (SPW) - FREE Research Report

Relational Investors Llc who is 10% Owner at SPX Corporation sold 183,083 shares at $98.45 on March 24, 2014. Following this transaction, the 10% Owner owned 6.3 million shares meaning that the stake was reduced by 2.84% with the 183,083-share transaction.

The shares most recently traded at $100.44, up $1.99, or 1.98% since the insider transaction. Historical insider transactions for SPX Corporation go as follows:

  • 4-Week # shares sold: 16,389
  • 12-Week # shares sold: 34,686
  • 24-Week # shares sold: 37,686

The average volume for SPX Corporation has been 320,400 shares per day over the past 30 days. SPX Corporation has a market cap of $4.5 billion and is part of the industrial goods sector and industrial industry. Shares are down 1.04% year-to-date as of the close of trading on Monday.

SPX Corporation provides specialized engineered solutions worldwide. It primarily operates in two segments, Flow Technology, and Thermal Equipment and Services. The stock currently has a dividend yield of 1.46%. The company has a P/E ratio of 23.8. Currently there are 8 analysts that rate SPX Corporation a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPW - FREE

TheStreet Quant Ratings

rates SPX Corporation as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

SPX Corporation Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null